Effect of continuous positive airway pressure on blood pressure and metabolic profile in women with sleep apnoea Source: Eur Respir J, 50 (2) 1700257; 10.1183/13993003.00257-2017 Year: 2017
Continuous positive airway pressure treatment in patients with OSA Source: Eur Respir Mon 2010; 50: 244-266 Year: 2010
Insulin resistance and patterns of continuous glucose monitoring in sleep apnoea patients: relationship with nocturnal hypoxemia and CPAP therapy Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Treatment of obstructive sleep-disordered breathing with positive airway pressure systems Source: Eur Respir Rev 2007; 16: 125-131 Year: 2007
The influence of continuous positive airway pressure (CPAP) on response to incremental exercise in sleep apnea patients Source: Eur Respir J 2004; 24: Suppl. 48, 567s Year: 2004
Continuous positive airway pressure treatment associates with decreasing glycosylated hemoglobin (HbA1 c) even in euglycemic obstructive sleep apnoea patients within normal HbA1 c range Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Residual sleep-disordered breathing during autotitrating continuous positive airway pressure therapy Source: Eur Respir J 2012; 39: 1391-1397 Year: 2012
Is there a metabolic effect of continuous positive airway pressure in sleep apnoea? Adherence should not be underestimated Source: Eur Respir J 2009; 34: 1209-1210 Year: 2009
Effect of continuous positive airway pressure on lipid profile in patients with severe OSAS Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018
Blood pressure response to CPAP treatment in subjects with obstructive sleep apnoea: the predictive value of 24-h ambulatory blood pressure monitoring Source: Eur Respir J, 50 (4) 1700651; 10.1183/13993003.00651-2017 Year: 2017
Pressure reduction during exhalation in sleep apnea patients treated by continuous positive airway pressure (CPAP) Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing Year: 2008
Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients Source: Eur Respir J 2006; 27: 1229-1235 Year: 2006
Screening of sleep apnea-induced hypertension and acute effect of continuous positive airway pressure Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009
Effect of continuous positive airway pressure on 24 h ambulatory blood pressure in hypertensive patients with OSA Source: Eur Respir J 2007; 30: Suppl. 51, 333s Year: 2007
The physiological effects of NIV and HFNT: HFNT is not continuous airway pressure Source: International Congress 2016 – Noninvasive ventilation versus high-flow nasal therapy for hypoxemic patients Year: 2016
Decrease in blood pressure during continuous positive airway pressure treatment for obstructive sleep apnoea: still searching for predictive factors Source: Eur Respir J, 54 (1) 1901219; 10.1183/13993003.01219-2019 Year: 2019
Predicting optimum continuous positive airway pressure (CPAP) from anthropometric and polysomnographic indices Source: Eur Respir J 2005; 26: Suppl. 49, 113s Year: 2005
Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment Source: Eur Respir J 2006; 27: 756-760 Year: 2006
Resting electrocardiographic (EKG) changes, the cardiovascular risk factors and the effect of CPAP (continuous positive airways pressure) therapy on high blood pressure evolution in patients with sleep apnoea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 564s Year: 2005
A comparison of different nasal positive pressure ventilation systems for the treatment of apnea of prematurity Source: Annual Congress 2006 - Premature infants, bronchopulmonary dysplasia, prediction, aetiology and treatment Year: 2006